至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients
J Immunol 2009.2015-03;
Lawrence M. KauvarRalph A. Tripp, Edward E. Walsh, Bruce A. Keyt andStephen F. Carroll, Stote L. Ellsworth, Larry J. Anderson,Park, Gizette Sperinde, Hai Wu, William D. Harriman,E
